Neurol. praxi. 2018;19(5):321-325 | DOI: 10.36290/neu.2018.048

Acute migraine therapy in the emergency room

MUDr. Zuzana Dean, MUDr. Andrea Petrovičová
Neurologická klinika, Fakultná nemocnica Nitra

Migraine is common in adult as well as pediatric population. In our countries a neurologist is often called to the emergency roomfor differential diagnosis of headache and its therapy management in contrast with western countries, where acute managementof migraine is the premise of the emergency specialist. Local standard treatment protocols rarely exist. The current article reviewsdata on treatment of acute headache patients in the acute care setting.

Keywords: migraine, primary headache, acute, treatment

Received: July 9, 2018; Accepted: July 31, 2018; Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dean Z, Petrovičová A. Acute migraine therapy in the emergency room. Neurol. praxi. 2018;19(5):321-325. doi: 10.36290/neu.2018.048.
Download citation

References

  1. Bigal ME, Bordini CA, Speciali JG. Intravenous metamizol (Dipyrone) in acute migraine treatment and in episodic tension-type headache - a placebo-controlled study. Cephalalgia 2001; 21(2): 90-95. Go to original source... Go to PubMed...
  2. Evers S, A'frab J, Fresea A, Goadsby PJ, Lindef M, Mayg AP, Sa'ndorh S. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. European Journal of Neurology 2009; 16: 968-981. Go to original source...
  3. Friedman BW, West J, Vinson DR, Minen MT, Restivo A, Gallagher EJ. Current management of migraine in U.S. Emergency Departments. An analysis of NHAMCS. Cephalgia 2014. Go to original source...
  4. Gelfand A, Goadsby PJ. A Neurologist's guide to acute migraine therapy in the emergency room. Neurohospitalist 2012; 2(2): 51-59. Go to original source... Go to PubMed...
  5. Leinisch E, Evers S, Kaempfe N, Kraemer C, Sostak P, Jürgens T, Straube A, May A. Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study. Pain. 2005; 117(3): 396-400. Go to original source...
  6. Marchenko A, Etwel F, Olutunfese O, Nickel C, Koren G, Nulman I. Pregnancy outcome following prenatal exposure to triptan medications: a meta-analysis. Headache 2015; 55: 490. Go to original source...
  7. McCarthy LH, Cowan RP. Comparison of parenteral treatments of acute primary headache in a large academic emergency department cohort. Cephalalgia 2015; 35: 807. Go to original source... Go to PubMed...
  8. Naeem F, Schrammb Ch, Friedman BW. Emergent management of primary headache: a review of current literature. Curr Opin Neurol. 2018, 31: 286-290. Go to original source... Go to PubMed...
  9. Orr SL, Friedman BW, Christie S, Minen MT, Bamford C, Kelley NE, Tepper D. Management of adults with acute migraine in the emergency department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies. Headache 2016; 56: 911-940. Go to original source...
  10. Sumamo Schellenberg E, Dryden DM, Pasichnyk D, Ha Ch, Vandermeer B, Friedman BW, Colman I, Rowe BH. Acute migraine treatment in emergency settings. Comparative Effectiveness Review No. 84. (Prepared by the University of Alberta Evidence-Based Practice Center under Contract No. 290-2007-10021-I.) AHRQ Publication No. 12(13)-EHC142-EF. Rockville, MD: Agency for Healthcare Research and Quality (US); 2012.
  11. Woldeamanuel YW, Rapoport AM, Cowan RP. The place of corticosteroids in migraine attack management: A 65-year systematic review with pooled analysis and critical appraisal. Cephalalgia 2015; 35(11): 996-1024. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.